FR7736M - - Google Patents

Info

Publication number
FR7736M
FR7736M FR164817A FR164817A FR7736M FR 7736 M FR7736 M FR 7736M FR 164817 A FR164817 A FR 164817A FR 164817 A FR164817 A FR 164817A FR 7736 M FR7736 M FR 7736M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR164817A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR164817A priority Critical patent/FR7736M/fr
Priority to BE737674D priority patent/BE737674A/xx
Priority to GB41485/69A priority patent/GB1247306A/en
Priority to DE19691944121 priority patent/DE1944121A1/de
Priority to ES371093A priority patent/ES371093A1/es
Application granted granted Critical
Publication of FR7736M publication Critical patent/FR7736M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR164817A 1968-09-02 1968-09-02 Expired FR7736M (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR164817A FR7736M (de) 1968-09-02 1968-09-02
BE737674D BE737674A (de) 1968-09-02 1969-08-19
GB41485/69A GB1247306A (en) 1968-09-02 1969-08-20 Heterocyclic derivatives of glyoxylic acid, process for their preparation and therapeutical composition containing same
DE19691944121 DE1944121A1 (de) 1968-09-02 1969-08-30 Neue Glyoxylsaeurederivate,Verfahren zu ihrer Herstellung und Verwendung als Pharmazeutika
ES371093A ES371093A1 (es) 1968-09-02 1969-09-01 Un procedimiento de preparacion de nuevos productos deriva-dos del acido glioxilico.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR164817A FR7736M (de) 1968-09-02 1968-09-02

Publications (1)

Publication Number Publication Date
FR7736M true FR7736M (de) 1970-03-09

Family

ID=8654167

Family Applications (1)

Application Number Title Priority Date Filing Date
FR164817A Expired FR7736M (de) 1968-09-02 1968-09-02

Country Status (5)

Country Link
BE (1) BE737674A (de)
DE (1) DE1944121A1 (de)
ES (1) ES371093A1 (de)
FR (1) FR7736M (de)
GB (1) GB1247306A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EP2189448B1 (de) 2003-06-17 2014-01-29 Arena Pharmaceuticals, Inc. Prozesse zur Trennung von 3-Benzazepin-Razematen
NZ578503A (en) 2003-06-17 2011-02-25 Arena Pharm Inc Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
EP1838677B1 (de) 2004-12-21 2009-09-09 Arena Pharmaceuticals, Inc. Kristalline formen von (r)-8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinhydrochlorid
CA2588941A1 (en) 2004-12-23 2006-07-06 Arena Pharmaceuticals, Inc. 5ht2c receptor modulator compositions and methods of use
CN101466684B (zh) 2006-04-03 2012-06-20 艾尼纳制药公司 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体
CA2670285A1 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
KR20140091458A (ko) 2010-09-01 2014-07-21 아레나 파마슈티칼스, 인크. 신장 손상을 갖는 개체에 대한 로카세린의 투여
CN103189359A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的光学活性酸盐
AU2011296003B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonist useful for weight management
KR20130101524A (ko) 2010-09-01 2013-09-13 아레나 파마슈티칼스, 인크. 5-ht2c 아고니스트의 비-흡습성 염
CA2886875A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
ES371093A1 (es) 1971-08-16
GB1247306A (en) 1971-09-22
BE737674A (de) 1970-02-02
DE1944121A1 (de) 1970-03-19

Similar Documents

Publication Publication Date Title
AU1946070A (de)
AU5506869A (de)
AU2374870A (de)
AU5184069A (de)
FR7736M (de)
AU6168869A (de)
AU6171569A (de)
AU2581067A (de)
AR203075Q (de)
AU2580267A (de)
BE709496A (de)
BE709415A (de)
BE727760A (de)
BE728281A (de)
AU2496167A (de)
BE727425A (de)
BE727309A (de)
AU479894A (de)
BE735824A (de)
BE727304A (de)
BE726350A (de)
BE723395A (de)
BE712980A (de)
BE709540A (de)
AU479393A (de)

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property
ST Notification of lapse